MARKET

CRY

CRY

CryoLife
NYSE

Real-time Quotes | Nasdaq Last Sale

21.57
+0.83
+4.00%
After Hours: 21.57 0 0.00% 16:11 12/04 EST
OPEN
20.99
PREV CLOSE
20.74
HIGH
21.67
LOW
20.93
VOLUME
134.76K
TURNOVER
--
52 WEEK HIGH
31.77
52 WEEK LOW
12.63
MARKET CAP
838.15M
P/E (TTM)
-58.0463
1D
5D
1M
3M
1Y
5Y
News
Financial
Releases
Corp Actions
Analysis
Profile
Heart Valve Repair and Replacement Market Share | Growth, Opportunities, Industry Applications, Analysis and Forecast To 2025
Heraldkeepers · 11/25 09:26
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020
, /PRNewswire/ -- , a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors and analysts to discuss progress with the Company's ongoing PROACT Xa trial on at .
PR Newswire - PRF · 11/19 13:30
CryoLife to Host Webcast Discussing PROACT Xa Clinical Trial on December 7, 2020
CryoLife, Inc. (NYSE: CRY), a leading cardiac and vascular surgery company focused on aortic disease, announced today that it will host a webcast for investors and analysts to discuss progress with the Company's ongoing PROACT Xa trial on December 7, 2020 at 4:00 p.m. EST.
PR Newswire · 11/19 13:30
Prosthetic Heart Valve/ Artificial Heart Valve Market Research Report by Application, by End User – Global Forecast to 2025 – Cumulative Impact of COVID-19
The Prosthetic Heart Valve/ Artificial Heart Valve Market is expected to exceed more than US$ 9 Billion by 2024 at a CAGR of 13% in the given forecast period.
Heraldkeepers · 11/18 11:33
Prosthetic Heart Valve Market Research Report by Type, by Sensor, by Technology, by End-use Industry – Global Forecast to 2025 – Cumulative Impact of COVID-19
The Global is expected to exceed more than USD$ 4 Billion by 2024; Growing at a CAGR of more than 9% in the given forecast period.
Heraldkeepers · 11/18 11:33
Greenlight takes fresh stakes in Twitter, Intel; exits Whirlpool, Tempur Sealy
David Einhorn's Greenlight Capital adds stakes CryoLife (CRY) with ~101K shares, Intel (INTC) with 300K shares, Twitter (TWTR) with ~488K shares, and Synnex (SNX) with 273K shares, according to its
Seekingalpha · 11/16 22:07
CryoLife (CRY) Q3 Earnings and Revenues Surpass Estimates
CryoLife (CRY) delivered earnings and revenue surprises of 1400.00% and 12.49%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?
Zacks · 11/05 00:35
US Heart Valve Repair and Replacement Market: Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020 - 2025
Heart Valve Repair and Replacement Market is valued at USD 6017.58 Million in 2018 and expected to reach USD 12104.80 Million by 2025 with the CAGR of 10.5% over the forecast period.
Heraldkeepers · 11/05 00:15
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CRY. Analyze the recent business situations of CryoLife through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 4 analysts

Strong Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CRY stock price target is 27.63 with a high estimate of 30.50 and a low estimate of 25.00.
EPS
Institutional Holdings
Institutions: 201
Institutional Holdings: 34.13M
% Owned: 87.85%
Shares Outstanding: 38.86M
TypeInstitutionsShares
Increased
43
2.59M
New
35
-540.48K
Decreased
41
3.12M
Sold Out
0
0
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.48%
Healthcare Equipment & Supplies
+1.33%
Key Executives
Chairman/President/Chief Executive Officer/Director
James Mackin
Chief Financial Officer/Chief Operating Officer/Executive Vice President
D. Ashley Lee
Senior Vice President/Chief Compliance Officer/General Counsel/Secretary
Jean Holloway
Senior Vice President/General Manager
Thomas Bogenschutz
Senior Vice President/Director of Sales/Director of Marketing
John Davis
Senior Vice President
Michael Simpson
Chief Accounting Officer/Vice President
Amy Horton
Vice President - Operations
Dennis Maier
Vice President/Director of Human Resources
Matthew Getz
Vice President
Scott Capps
Lead Director/Independent Director
Ronald McCall
Independent Director
Thomas Ackerman
Independent Director
Daniel Bevevino
Independent Director
Marna Borgstrom
Independent Director
James Bullock
Independent Director
Jeffrey Burbank
Independent Director
Harvey Morgan
Independent Director
Jon Salveson
  • Dividends
  • Splits
  • Insider Activity
Declaration Date
Dividend Per Share
Ex-Div Date
10/23/2015
Dividend USD 0.03
12/09/2015
07/22/2015
Dividend USD 0.03
09/09/2015
05/22/2015
Dividend USD 0.03
06/10/2015
02/13/2015
Dividend USD 0.03
03/11/2015
10/23/2014
Dividend USD 0.03
12/10/2014
07/30/2014
Dividend USD 0.03
09/10/2014
05/23/2014
Dividend USD 0.03
06/11/2014
02/20/2014
Dividend USD 0.027
03/12/2014
11/21/2013
Dividend USD 0.027
12/11/2013
08/21/2013
Dividend USD 0.027
09/11/2013
05/28/2013
Dividend USD 0.027
06/12/2013
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
About CRY
CryoLife, Inc. (CryoLife) is a medical device manufacturer and processor, and is engaged in the distribution of medical devices and implantable human tissues used in cardiac surgical procedures. The Company operates through two segments: Medical Devices and Preservation Services. The Medical Devices segment includes medical devices, such as Surgical Sealants, BioGlue products, JOTEC products, On-X products, CardioGenesis cardiac laser therapy, PerClot, PhotoFix, and NEXUS. The Preservation Services segment includes services revenues from the preservation of cardiac and vascular implantable human tissues.
More
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Cryolife Inc stock information, including NYSE:CRY real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CRY stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CRY stock methods without spending real money on the virtual paper trading platform.